Abstract
In defying conventional views that dismissed itch as trivial, I persisted in studying basophils and ILC2s in human skin and atopic dermatitis. My research on JAK inhibitors for itch ultimately led to FDA-approved drugs. This is my story of disregarding categories and definitions—a story about an unconventional path in science that emphasizes innovation over conformity.
Original language | English |
---|---|
Pages (from-to) | 4814-4818 |
Number of pages | 5 |
Journal | Cell |
Volume | 187 |
Issue number | 18 |
DOIs |
|
State | Published - 5 Sep 2024 |